- Home
- TRGP vs CAH Comparison
TRGP vs CAH Comparison
Compare TRGP & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRGP | CAH |
|---|---|---|
| Founded | 2005 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Other Pharmaceuticals |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.1B | 52.0B |
| IPO Year | 2010 | 1994 |
Fundamental Metrics
Financial Performance| Metric | TRGP | CAH |
|---|---|---|
| Price | $225.50 | $222.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 11 |
| Target Price | $212.17 | ★ $229.09 |
| AVG Volume (30 Days) | 1.3M | ★ 1.6M |
| Earning Date | 05-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.23% | 0.92% |
| EPS Growth | 47.91 | ★ 86.96 |
| EPS | ★ 8.49 | 1.88 |
| Revenue | $17,028,300,000.00 | ★ $222,578,000,000.00 |
| Revenue This Year | $41.12 | $17.34 |
| Revenue Next Year | $4.81 | $8.95 |
| P/E Ratio | ★ $26.41 | $118.35 |
| Revenue Growth | ★ 3.95 | N/A |
| 52 Week Low | $144.14 | $120.72 |
| 52 Week High | $232.86 | $230.20 |
Technical Indicators
Market Signals| Indicator | TRGP | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 76.64 | 55.69 |
| Support Level | $217.79 | $213.75 |
| Resistance Level | $205.93 | $225.91 |
| Average True Range (ATR) | 5.96 | 6.74 |
| MACD | 1.37 | 0.09 |
| Stochastic Oscillator | 80.70 | 67.53 |
Price Performance
Historical ComparisonAbout TRGP Targa Resources Inc.
Targa Resources is a midstream firm that primarily operates gathering and processing assets with substantial positions in the Permian, Stack, Scoop, and Bakken plays. It has fractionation capacity at Mont Belvieu and operates a liquefied petroleum gas export terminal. The Grand Prix natural gas liquids pipeline is another important asset.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.